Wockhardt has informed that a meeting of the Board of Directors of the Company will be held on September 15, 2014, inter alia, to consider and approve amalgamation of two wholly owned subsidiaries viz Wockhardt Biopharm Limited and Vinton Healthcare Limited with Wockhardt Limited.
The above information is a part of company’s filings submitted to BSE